Cargando…

The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)

BACKGROUND: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkenmaier, Christof, Suess, Olaf, Pfeiffer, Michael, Burger, Ralf, Schmieder, Kirsten, Wegener, Bernd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944216/
https://www.ncbi.nlm.nih.gov/pubmed/20819219
http://dx.doi.org/10.1186/1471-2474-11-199
_version_ 1782187096477270016
author Birkenmaier, Christof
Suess, Olaf
Pfeiffer, Michael
Burger, Ralf
Schmieder, Kirsten
Wegener, Bernd
author_facet Birkenmaier, Christof
Suess, Olaf
Pfeiffer, Michael
Burger, Ralf
Schmieder, Kirsten
Wegener, Bernd
author_sort Birkenmaier, Christof
collection PubMed
description BACKGROUND: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy. METHODS/DESIGN: Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs. DISCUSSION: This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted. TRIAL REGISTRATION: Clinical Trials NCT00810433
format Text
id pubmed-2944216
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29442162010-09-24 The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) Birkenmaier, Christof Suess, Olaf Pfeiffer, Michael Burger, Ralf Schmieder, Kirsten Wegener, Bernd BMC Musculoskelet Disord Study Protocol BACKGROUND: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy. METHODS/DESIGN: Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs. DISCUSSION: This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted. TRIAL REGISTRATION: Clinical Trials NCT00810433 BioMed Central 2010-09-06 /pmc/articles/PMC2944216/ /pubmed/20819219 http://dx.doi.org/10.1186/1471-2474-11-199 Text en Copyright ©2010 Birkenmaier et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Birkenmaier, Christof
Suess, Olaf
Pfeiffer, Michael
Burger, Ralf
Schmieder, Kirsten
Wegener, Bernd
The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_full The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_fullStr The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_full_unstemmed The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_short The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
title_sort european multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (go-lif)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944216/
https://www.ncbi.nlm.nih.gov/pubmed/20819219
http://dx.doi.org/10.1186/1471-2474-11-199
work_keys_str_mv AT birkenmaierchristof theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT suessolaf theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT pfeiffermichael theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT burgerralf theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT schmiederkirsten theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT wegenerbernd theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT birkenmaierchristof europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT suessolaf europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT pfeiffermichael europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT burgerralf europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT schmiederkirsten europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif
AT wegenerbernd europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif